Proteomic and genomic biomarkers for Non-Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha-1 antitrypsin.
Zahra NajafiAbdolreza MohamadniaRahim AhmadiMinoo MahmoudiNaghmeh BahramiAdnan KhosraviHamidreza JamaatiPayam TabarsiMehdi Kazempour-DizajiSadegh ShirianPublished in: Cancer medicine (2020)
The results of this study showed that there are some differences in term of protein content between the normal and cancerous lung tissues. Further studies are needed to evaluate these proteins that investigate whether these proteins can candidate as biomarkers to use in the early diagnosis of patients with NSCLC.